Arkolith/Insider Trading/TCRX/Form 4

Lynx1 Capital Management LP

10% OwnerTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Apr 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 19, 2024Buy(P)5.0M$7.13$35.6M5.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-24-003030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML